Connecting the dots in Huntington's disease with protein interaction networks

Genome Biology

Volumn 6, Issue 3, 2005, Pages

  Giorgini, Flaviano ^a   Muchowski, Paul J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE INTERACTOR 1; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HUNTINGTIN; HUNTINGTIN INTERACTING PROTEIN; PROTEIN; PROTEIN HTT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

DEGENERATIVE DISEASE; FUNCTIONAL GENOMICS; HUNTINGTON CHOREA; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; SHORT SURVEY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL CYCLE PROTEINS; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN INTERACTION MAPPING; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 16844370705     PISSN: 14656906     EISSN: None     Source Type: Journal    
DOI: 10.1186/gb-2005-6-3-210     Document Type: Short Survey

References (31)

1. The Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72: 71-983.
2. Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S: Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci 2001, 24: 82-188.
3. Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO, Leavitt BR, Cattaneo E, Ferrante RJ, Hayden MR, et al.: Depletion of wild-type huntingtin in mouse models of neurologic diseases. J Neurochem 2003, 87:101-106.
4. Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, Droege A, Lindenberg KS, Knoblich M, Haenig C, Friedlander RM: A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell 2004, 15: 53-865.
5. Li SH, Li XJ: Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 2004, 20: 46-154.
6. Harjes P, Wanker EE: The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 2003, 28:425-433.
7. Qin ZH, Wang Y, Sapp E, Cuiffo B, Wanker E, Hayden MR, Kegel KB, Aronin N, DiFiglia M: Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J Neurosci 2004, 24:269-281.
8. Andrade MA, Bork P: HEAT repeats in the Huntington's disease protein. Nat Genet 1995, 11:115-116.
9. Neuwald AF, Hirano T: HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions. Genome Res 2000, 10:1445-1452.
10. Cha JH: Transcriptional dysregulation in Huntington's disease. Trends Neurosci 2000, 23:387-392.
11. Sugars KL, Rubinsztein DC: Transcriptional abnormalities in Huntington disease. Trends Genet 2003, 19:233-238.
12. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, et al.: Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001, 413: 39-743.
13. Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PA, et al.: Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 2003, 100:2041-2046.
14. Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM: Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 2003, 23:9418-9427.
15. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F, Kellendonk C, Gau D, Kapfhammer J, et al.: Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 2002, 31:47-54.
16. Schwikowski B, Uetz P, Fields S: A network of protein-protein interactions in yeast. Nat Biotechnol 2000, 18:1257-1261.
17. Ge H, Walhout AJ, Vidal M: Integrating 'omic' information: a bridge between genomics and systems biology. Trends Genet 2003, 19:551-560.
18. Fields S: Proteomics. Proteomics in genomeland. Science 2001, 291:1221-1224.
19. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, et al.: A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000, 403:623-627.
20. Ito T, Tashiro K, Muta S, Ozawa R, Chiba T, Nishizawa M, Yamamoto K, Kuhara S, Sakaki Y: Toward a protein-protein interaction map of the budding yeast: A comprehensive system to examine two-hybrid interactions in all possible combinations between the yeast proteins. Proc Natl Acad Sci USA 2000, 97:1143-1147.
21. Fields S, Song O: A novel genetic system to detect protein-protein interactions. Nature 1989, 340:245-246.
22. Miller J, Stagljar I: Using the yeast two-hybrid system to identify interacting proteins. Methods Mol Biol 2004, 261: 47-262.
23. Zhang H, Webb DJ, Asmussen H, Horwitz AF: Synapse formation is regulated by the signaling adaptor GIT1. J Cell Biol 2003, 161:131-142.
24. Claing A, Perry SJ, Achiriloaie M, Walker JK, Albanesi JP, Lefkowitz RJ, Premont RT: Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc Natl Acad Sci USA 2000, 97:1119-1124.
25. Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ: Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 2003, 302:1769-1772.
26. Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ: A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington's disease. Nat Genet 2005, in press.
27. Kazemi-Esfarjani P, Benzer S: Genetic suppression of polyglutamine toxicity in Drosophila. Science 2000, 287:1837-1840.
28. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, et al.: Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 2000, 408:101-106.
29. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI, Plasterk RH: Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci USA 2004, 101:6403-6408.
30. Jimenez-Sanchez G, Childs B, Valle D: Human disease genes. Nature 2001, 409:853-855.
31. Jazzlandscapes.com [http://www.jazzlandscapes.com]